Organogenesis Holdings (ORGO) stock
ORGO's Quality Score rose 1 point on Mon, Oct 5, to -4. Traded heavy volume.
Follow ORGO's trial news. Pro members can get an alert when Organogenesis Holdings files news, and see its trials, share raises, and its CEO's filings.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
What's next for ORGO
From Organogenesis Holdings’s SEC filings and ClinicalTrials.gov: the company’s own words, the registry’s dates, and arithmetic, not a forecast. Companies often miss their own dates.
Dilution on the horizon
- Shelf registration (S-3, filed Aug 8, 2024)
- At-the-market share sales program (424B5, filed Aug 6, 2026)
Insiders
Director Arthur S Leibowitz bought 5,000 shares on Mar 9. 1 more insider trade this year.
FDA dates in the next 60 days
Decision dates and advisory committee meetings the companies have announced in their own filings, soonest first and small companies first.
- In 24 daysINOInovio Pharmaceuticals
INOINO-3107
- In 35 daysNRXPNRX Pharmaceuticals
NRXPDrug not named
- In 47 daysCAPRCapricor Therapeutics
CAPRDrug not named
Why it's down
Down 46% in 3 months, 25% under its 50-day average.
Down more than its industry: the 90 other stocks in it fell a median 6% over the same 3 months.
−3Long-term trend below a falling 200-day average, down over one year, down over two years
2 more things pulling ORGO's score down, for Pro members
Why ORGO lags the market
Organogenesis returned -90% over five years to the S&P 500's +91%; its price went from 90 times earnings to 9.
Free cash flow went from -$12.2M in fiscal 2020 to -$24.5M in fiscal 2025.
2 more drivers and the timeline, for Pro members
What's next
Expected to report Thu Nov 5, after the close
After its last 4 reports it closed +0.6% on average, higher 1 of 4 times.
What would turn ORGO's score around: 6 things, for Pro members
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
ORGO has 1 of 14 checks firing
One per group is shown here.
Also on the chart
- RSI 1429.4
- MACD (12, 26, 9)Above signal
- 50-day average$1.75
- 200-day average$2.74
- ADX 1442.9
- Resistance$1.50
- Bollinger Bands (20, 2)Inside
- Volume3.0x
How ORGO ranks in Pharma
ORGO is #84 of 91 by Quality Score. The top three are shown with their scores, and more by name.
ABBV10/1421
GMAB8/1416
CYRX8/1413
OMEROpen for its score
OPKOpen for its score
PBHOpen for its score
PFEOpen for its score
ORGO1/14-4
When does ORGO report earnings, and what happens after?
Expected to report Thu Nov 5, after the close (in 30 days). Not yet confirmed by the company.
| Reported | When | Gap | Reaction | 5 sessions |
|---|---|---|---|---|
| Aug 6, 2026After close | After close | -27.4% | -22.8% | -27.0% |
| May 7, 2026After close | After close | -19.4% | -6.3% | +2.4% |
| Feb 26, 2026After close | After close | +0.8% | -13.2% | -21.6% |
| Nov 6, 2025After close | After close | +31.4% | +44.7% | +59.6% |
About Organogenesis Holdings
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
Pro members see every line of every stock's score.
- Real-time prices, no delay
- Every line of ORGO's score, with the points and the reason
- All 14 checks on ORGO and on all 3,243 stocks
- Every stock ranked, with the chart
- Every filing, and optional alerts on ORGO
Straight Answers
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Where does the data come from?
Daily bars, quotes, reference data, headlines, and short interest come from Massive, formerly Polygon, a licensed market data vendor. The age of the quotes is shown at the top of every page. Insider trades, notable holders and profits come straight from the SEC. That means Form 4 filings, 13F filings and XBRL financial data on EDGAR. Government filings come from the public STOCK Act and Office of Government Ethics disclosures. The market-wide headlines on the market line also come from the public headline feeds CNBC, MarketWatch and Yahoo Finance publish, shown as the headline, the source and a link to the article. Splits, dividends, and the financial statements on each ticker page come from the vendor's reference data. The 8-K filings on EDGAR are read for the items that move a price. Five years of history is loaded for every stock. So the 200-day and 52-week checks rest on real history. Options flow is not part of the product.
Do I need an account?
Not to start. Tap any green button and you're in, free, with no email and no password. To keep going, create a free account with Google, Apple, or your email. There is no password to make up.
Is this investment advice?
No. It is a screening tool that scores stocks on the chart, the company's own results, and the news and filings. It does not know your situation and it is not a recommendation to buy or sell anything. Please do your own research.